ATE319474T1 - Behandlung von autoimmunkrankheiten durch orale verabreichung von autoantigenen - Google Patents
Behandlung von autoimmunkrankheiten durch orale verabreichung von autoantigenenInfo
- Publication number
- ATE319474T1 ATE319474T1 AT92900084T AT92900084T ATE319474T1 AT E319474 T1 ATE319474 T1 AT E319474T1 AT 92900084 T AT92900084 T AT 92900084T AT 92900084 T AT92900084 T AT 92900084T AT E319474 T1 ATE319474 T1 AT E319474T1
- Authority
- AT
- Austria
- Prior art keywords
- autoantigens
- oral administration
- treatment
- autoimmune diseases
- autoimmune disease
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
- A61K39/36—Allergens from pollen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US59693690A | 1990-10-15 | 1990-10-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE319474T1 true ATE319474T1 (de) | 2006-03-15 |
Family
ID=24389347
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT92900084T ATE319474T1 (de) | 1990-10-15 | 1991-10-15 | Behandlung von autoimmunkrankheiten durch orale verabreichung von autoantigenen |
Country Status (13)
Country | Link |
---|---|
US (1) | US6019971A (de) |
EP (1) | EP0553291B1 (de) |
JP (1) | JP2635444B2 (de) |
KR (1) | KR0140841B1 (de) |
AT (1) | ATE319474T1 (de) |
AU (2) | AU9023791A (de) |
CA (1) | CA2092905C (de) |
DE (1) | DE69133516T2 (de) |
ES (1) | ES2258261T3 (de) |
HU (1) | HUT69942A (de) |
IL (1) | IL99754A (de) |
NO (1) | NO314878B1 (de) |
WO (1) | WO1992006708A1 (de) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5843445A (en) * | 1987-06-24 | 1998-12-01 | Autoimmune, Inc. | Method of treating rheumatoid arthritis with type II collagen |
US5869054A (en) * | 1987-06-24 | 1999-02-09 | Autoimmune Inc. | Treatment of multiple sclerosis by oral administration of autoantigens |
US5849298A (en) * | 1987-06-24 | 1998-12-15 | Autoimmune Inc. | Treatment of multiple sclerosis by oral administration of bovine myelin |
US6645504B1 (en) | 1987-06-24 | 2003-11-11 | Autoimmune Inc. | Bystander suppression of type I diabetes by oral administration of glucagon |
AU9023791A (en) * | 1990-10-15 | 1992-05-20 | Brigham And Women's Hospital | Treatment of autoimmune diseases by oral administration of autoantigens |
DK0590060T3 (da) * | 1991-06-21 | 1998-05-11 | Univ Cincinnati | Oralt indgivelige terapeutiske proteiner samt fremgangsmåde til fremstilling |
US6613332B1 (en) | 1991-06-21 | 2003-09-02 | The University Of Cincinnati | Oral administration of therapeutic proteins |
DE4125400C2 (de) * | 1991-07-31 | 2000-08-17 | Edwin Klaus | Verwendung von unlöslichem Kollagen zur Behandlung von degenerativen, nicht entzündlichen Gelenkprozessen |
KR950700082A (ko) * | 1992-02-28 | 1995-01-16 | 로버트 씨. 비숍 | 바이스탠더(bystander)에 의한 자가면역질환을 처치하는 방법 |
JP3845447B2 (ja) * | 1992-09-25 | 2006-11-15 | オートイミューン インク | タイプ▲ii▼コラーゲンによるリウマチ性関節炎治療方法 |
SG52402A1 (en) * | 1992-12-22 | 1998-09-28 | Univ Cincinnati | Oral administration of immunologically active biomolecules and other therapeutic proteins |
ES2141732T3 (es) * | 1993-02-02 | 2000-04-01 | Edwin Dr Klaus | Uso de colagenos para el tratamiento de procesos articulares patologicos. |
EP0705108A4 (de) * | 1993-06-02 | 1997-08-06 | Tvw Telethon Inst Child Health | Verwendung von kryptischen peptiden zur induktion immunologisches toleranz |
GB9319429D0 (en) | 1993-09-21 | 1993-11-03 | London Health Ass | Methods and products for controlling immune responses in mammals |
US6379670B1 (en) | 1994-11-18 | 2002-04-30 | Neurocrine Biosciences, Inc. | Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein |
US6251396B1 (en) | 1994-11-18 | 2001-06-26 | Neurocrine Biosciences, Inc. | Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein |
US5856446A (en) * | 1995-07-07 | 1999-01-05 | Autoimmune Inc. | Method of treating rheumatoid arthritis with low dose type II collagen |
BR9706922A (pt) * | 1996-01-05 | 1999-07-20 | Autoimmune Inc | Método para facilitar a remoção de membrana pericondrial de tecido de cartilagem vertebral não processado para remover proteoglicanos de tecido contendo colágeno tipo ii e para obter um produto contendo colágeno tipo ii |
WO1997046253A2 (en) * | 1996-06-03 | 1997-12-11 | Powderject Vaccines, Inc. | Immunotherapy for autoimmune disease |
WO1998006861A2 (en) * | 1996-08-15 | 1998-02-19 | Agrivax Incorporated | Delivery of tolerogenic antigens via edible plants or plant-derived products |
US6923964B1 (en) | 1997-12-02 | 2005-08-02 | Neuralab Limited | Active immunization of AScr for prion disorders |
US6913745B1 (en) | 1997-12-02 | 2005-07-05 | Neuralab Limited | Passive immunization of Alzheimer's disease |
US6710226B1 (en) | 1997-12-02 | 2004-03-23 | Neuralab Limited | Transgenic mouse assay to determine the effect of Aβ antibodies and Aβ Fragments on alzheimer's disease characteristics |
US6743427B1 (en) | 1997-12-02 | 2004-06-01 | Neuralab Limited | Prevention and treatment of amyloidogenic disease |
TWI239847B (en) | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
US20080050367A1 (en) | 1998-04-07 | 2008-02-28 | Guriq Basi | Humanized antibodies that recognize beta amyloid peptide |
US6787523B1 (en) | 1997-12-02 | 2004-09-07 | Neuralab Limited | Prevention and treatment of amyloidogenic disease |
US7790856B2 (en) | 1998-04-07 | 2010-09-07 | Janssen Alzheimer Immunotherapy | Humanized antibodies that recognize beta amyloid peptide |
US6750324B1 (en) | 1997-12-02 | 2004-06-15 | Neuralab Limited | Humanized and chimeric N-terminal amyloid beta-antibodies |
US7691829B2 (en) * | 1998-03-24 | 2010-04-06 | Petito George D | Composition and method for healing tissues |
US20050208114A1 (en) * | 1998-03-24 | 2005-09-22 | Petito George D | Composition and method for healing tissues |
US20030147882A1 (en) | 1998-05-21 | 2003-08-07 | Alan Solomon | Methods for amyloid removal using anti-amyloid antibodies |
US6787637B1 (en) | 1999-05-28 | 2004-09-07 | Neuralab Limited | N-Terminal amyloid-β antibodies |
UA81216C2 (en) | 1999-06-01 | 2007-12-25 | Prevention and treatment of amyloid disease | |
US7462486B2 (en) * | 2000-05-12 | 2008-12-09 | Oregon Health & Science University | Methods of selecting T cell receptor V peptides for therapeutic use |
US7371385B2 (en) * | 2000-05-12 | 2008-05-13 | Oregon Health & Science University | Method of treating immune pathologies with low dose estrogen |
CA2410563C (en) | 2000-05-24 | 2013-04-23 | John M. Hallenbeck | Methods for preventing strokes by inducing tolerance to e-selectin |
US7700751B2 (en) | 2000-12-06 | 2010-04-20 | Janssen Alzheimer Immunotherapy | Humanized antibodies that recognize β-amyloid peptide |
MY139983A (en) | 2002-03-12 | 2009-11-30 | Janssen Alzheimer Immunotherap | Humanized antibodies that recognize beta amyloid peptide |
TWI374893B (en) | 2003-05-30 | 2012-10-21 | Janssen Alzheimer Immunotherap | Humanized antibodies that recognize beta amyloid peptide |
EP1786465A4 (de) * | 2004-07-30 | 2009-01-21 | Univ Oregon Health & Science | Verfahren zur detektion und behandlung von autoimmunstörungen |
WO2006066089A1 (en) | 2004-12-15 | 2006-06-22 | Neuralab Limited | Humanized amyloid beta antibodies for use in improving cognition |
US8784810B2 (en) | 2006-04-18 | 2014-07-22 | Janssen Alzheimer Immunotherapy | Treatment of amyloidogenic diseases |
WO2009017467A1 (en) | 2007-07-27 | 2009-02-05 | Elan Pharma International Limited | Treatment of amyloidogenic diseases |
US8003097B2 (en) | 2007-04-18 | 2011-08-23 | Janssen Alzheimer Immunotherapy | Treatment of cerebral amyloid angiopathy |
JO3076B1 (ar) | 2007-10-17 | 2017-03-15 | Janssen Alzheimer Immunotherap | نظم العلاج المناعي المعتمد على حالة apoe |
US9067981B1 (en) | 2008-10-30 | 2015-06-30 | Janssen Sciences Ireland Uc | Hybrid amyloid-beta antibodies |
CN104922199A (zh) * | 2015-07-14 | 2015-09-23 | 无限极(中国)有限公司 | 一种保护骨关节组合物及其应用 |
EP3621985A4 (de) | 2017-05-11 | 2021-03-17 | Avicenna Nutraceutical, LLC | Verfahren zur erzeugung von kollagen |
EP4031167A4 (de) | 2019-09-16 | 2023-07-19 | Figene, LLC | Behandlung von bandscheibendegenerativen erkrankungen und stimulierung der proteoglykansynthese durch konditionierte fibroblastenmedien und formulierungen davon |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4350682A (en) * | 1979-05-11 | 1982-09-21 | Lescarden Ltd. | Cartilage extraction processes and products |
ATE128627T1 (de) * | 1986-06-30 | 1995-10-15 | Massachusetts Inst Technology | Immunomodulare mittel und deren verwendung. |
CA1302880C (en) * | 1986-07-25 | 1992-06-09 | Peter Koepff | Agents for the treatment of arthroses |
US5849298A (en) * | 1987-06-24 | 1998-12-15 | Autoimmune Inc. | Treatment of multiple sclerosis by oral administration of bovine myelin |
US5399347A (en) * | 1987-06-24 | 1995-03-21 | Autoimmune, Inc. | Method of treating rheumatoid arthritis with type II collagen |
AU632991B2 (en) * | 1987-06-24 | 1993-01-21 | Autoimmune, Inc. | Treatment of autoimmune diseases by oral administration of autoantigens |
US5843445A (en) * | 1987-06-24 | 1998-12-01 | Autoimmune, Inc. | Method of treating rheumatoid arthritis with type II collagen |
CA1340012C (en) * | 1987-08-17 | 1998-08-25 | Trustees Of Leland Stanford Jr. University | Peptide determinant associated with immunity |
AU642693B2 (en) * | 1989-12-20 | 1993-10-28 | Autoimmune, Inc. | Improved treatment of autoimmune diseases by aerosol administration of auto antigens |
US5075112A (en) * | 1990-02-12 | 1991-12-24 | Cartilage Technologies Inc. | Method of and dosage unit for inhibiting angiogenesis or vascularization in an animal using shark cartilage |
EP0782859A1 (de) * | 1990-03-02 | 1997-07-09 | Autoimmune, Inc. | Erhöhung der Verminderungsregulation von Autoimmunkrankheiten durch orale Verabreichung von Autoantigenen |
AU9023791A (en) * | 1990-10-15 | 1992-05-20 | Brigham And Women's Hospital | Treatment of autoimmune diseases by oral administration of autoantigens |
DE4125400C2 (de) * | 1991-07-31 | 2000-08-17 | Edwin Klaus | Verwendung von unlöslichem Kollagen zur Behandlung von degenerativen, nicht entzündlichen Gelenkprozessen |
-
1991
- 1991-10-15 AU AU90237/91A patent/AU9023791A/en not_active Abandoned
- 1991-10-15 CA CA002092905A patent/CA2092905C/en not_active Expired - Lifetime
- 1991-10-15 HU HU9301089A patent/HUT69942A/hu unknown
- 1991-10-15 ES ES92900084T patent/ES2258261T3/es not_active Expired - Lifetime
- 1991-10-15 WO PCT/US1991/007542 patent/WO1992006708A1/en active IP Right Grant
- 1991-10-15 DE DE69133516T patent/DE69133516T2/de not_active Expired - Lifetime
- 1991-10-15 EP EP92900084A patent/EP0553291B1/de not_active Expired - Lifetime
- 1991-10-15 JP JP4500704A patent/JP2635444B2/ja not_active Expired - Lifetime
- 1991-10-15 KR KR1019930701083A patent/KR0140841B1/ko not_active IP Right Cessation
- 1991-10-15 AT AT92900084T patent/ATE319474T1/de not_active IP Right Cessation
- 1991-10-15 IL IL9975491A patent/IL99754A/en not_active IP Right Cessation
-
1993
- 1993-04-14 NO NO19931372A patent/NO314878B1/no not_active IP Right Cessation
-
1995
- 1995-06-05 US US08/463,946 patent/US6019971A/en not_active Expired - Lifetime
- 1995-09-01 AU AU30409/95A patent/AU693232B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
CA2092905A1 (en) | 1992-04-16 |
HUT69942A (en) | 1995-09-28 |
IL99754A (en) | 1996-08-04 |
HU9301089D0 (en) | 1993-07-28 |
AU693232B2 (en) | 1998-06-25 |
DE69133516D1 (de) | 2006-05-04 |
CA2092905C (en) | 2002-01-08 |
AU3040995A (en) | 1995-11-30 |
NO931372L (no) | 1993-05-18 |
IL99754A0 (en) | 1992-08-18 |
AU9023791A (en) | 1992-05-20 |
EP0553291B1 (de) | 2006-03-08 |
NO931372D0 (no) | 1993-04-14 |
NO314878B1 (no) | 2003-06-10 |
KR0140841B1 (ko) | 1998-06-01 |
US6019971A (en) | 2000-02-01 |
ES2258261T3 (es) | 2006-08-16 |
JP2635444B2 (ja) | 1997-07-30 |
EP0553291A1 (de) | 1993-08-04 |
EP0553291A4 (en) | 1994-11-30 |
WO1992006708A1 (en) | 1992-04-30 |
KR930702026A (ko) | 1993-09-08 |
JPH05508662A (ja) | 1993-12-02 |
DE69133516T2 (de) | 2006-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE319474T1 (de) | Behandlung von autoimmunkrankheiten durch orale verabreichung von autoantigenen | |
ATE130762T1 (de) | Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen. | |
DK0627933T3 (da) | Bystander-suppression af autoimmune sygdomme | |
ATE190496T1 (de) | Behandlung von autoimmunkrankheiten durch verabreichung von autoantigenen in form von aerosol | |
ATE157257T1 (de) | Verstärkung der unterdrückungsregulation von autoimmunkrankheiten durch orale oder enterale verabreichung von autoantigenen | |
RU94027680A (ru) | Паращитовидный гормон и ралоксифон для увеличения массы кости, фармацевтический состав и способ увеличения костной массы | |
EA200401473A1 (ru) | Предотвращение и лечение амилоидогенного заболевания | |
DK0430474T3 (da) | Præparater med vedvarende frigivelse til behandling af periodontal sygdom | |
DE60132444D1 (de) | Behandlung von reizkolon-syndrom oder -krankheit | |
ATE179333T1 (de) | Immunotherapeutische zubereitung | |
PT1237562E (pt) | Processo de preparacao de extractos de micania contendo micanolida e di-hidromicanolida e utilizacao no tratamento das doencas proliferativas | |
DE3373978D1 (en) | Composition for the care or treatment of the human skin | |
RU94002713A (ru) | Способ лечения детей с синдромом удлиненного интервала qт (романо-уорда) | |
ATE65394T1 (de) | Behandlung von knochenschwund. | |
RU93046022A (ru) | Способ лечения бронхопневмонии телят |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |